Biocon Biologics, a leading subsidiary of Biocon Ltd., has achieved a significant milestone with the U.S. Food and Drug Administration (USFDA) approval for its biosimilar version of Janssen's Stelara (Ustekinumab). This approval, granted under the rigorous 351(k) regulatory pathway, is poised to address the growing
Launches Single-Use Assemblies & ASTC UV-Shield Tubing for Indian customers Freudenberg, a worldwide technology business based in Germany, will attend CPhI & PMEC India 2024 on November 26-28. Freudenberg, a trusted supplier of biopharmaceutical devices, systems, high-performance sealing, and filtering solutions, services to pharmaceutical and
OneSource Specialty Pharma, a newly formed CDMO, is formed from the merger of three CDMO businesses within the Strides Group, which boasts a 30-year track-record of excellence in manufacturing and quality. The company is launching its new brand identity with a strong emphasis on customer
Program partners with government hospitals to strengthen drug development in the country Roche Pharma India, world’s leading biopharmaceutical company today announced the launch of its Clinical Trial Excellence project in India with an objective to strengthen the capabilities of public health institutions to do clinical trials
A. Menarini India Private Limited (‘Menarini India’), part of the Menarini Group, the world’s largest Italian biopharmaceutical company and a global leader in dermatology and aesthetics solutions worldwide, recently announced its expansion into the Indian aesthetics market. With a strong commitment to continuous innovation and
5th edition of CII UP Health Summit gets underway Takeda Biopharmaceuticals India Private Limited (formerly Baxalta Bioscience India Pvt Ltd) – a global values-based, R&D-driven biopharmaceutical leader in innovative healthcare solutions presented an industry perspective on equitable access to healthcare during the 5th edition of the
Enabling ART centres/clinics to implement the requirements of the Assisted Reproductive Technology Regulations, 2021 for greater compliance….. Mumbai: Ahead of the World IVF Day, Bharat Serums and Vaccines Limited (BSV) a leading biopharmaceutical company in India has roped in Bureau Veritas (India) Pvt. Ltd. (BVIL), a
The approval allows treatment of heart failure patients irrespective of the ejection fraction based on new trial DELIVER conducted by AstraZeneca AstraZeneca Pharma India Ltd. (AstraZeneca India), a science-led biopharmaceutical company, announced it has received extended indication approval from the Drugs Controller General of India
Tremelimumab in combination with Durvalumab is indicated for the treatment of patients with unresectable hepatocellular carcinoma (uHCC) AstraZeneca Pharma India Ltd. (AstraZeneca India), a science-led biopharmaceutical company, announced it has received approval from the Central Drugs Standard Control Organisation (CDSCO) for its cancer drug Tremelimumab Concentrate
AstraZeneca Pharma India Ltd. (AstraZeneca India), a leading biopharmaceutical company, announced the appointment of Bhavana Agrawal as Chief Finance Officer (CFO) with effect from October 1, 2023, following a transition period. She succeeds Rajesh Marwaha, who is retiring as CFO and full-time director of the
